Bayer Aspirin Prevention Comparative Claims Vs. Plavix Targeted By FDA
Executive Summary
Marketing claims comparing the use of Bayer Aspirin for heart attack and stroke prevention to the prescription antiplatelet drug Plavix are targeted by FDA in a Dec. 17 warning letter to Bayer.